Business Wire
BusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex Times
Back to front
Disney brands, MRI technology, and AI copyright battles are in focus as Wall Street branding calls DIS a “cheap” buy
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 7, 6:51 PM EDT

Disney brands, MRI technology, and AI copyright battles are in focus as Wall Street branding calls DIS a “cheap” buy

A market-news note highlighted Walt Disney (DIS) as a “top cheap” stock with Strong Buy ratings, pointing to a new Disney-healthcare partnership and renewed legal momentum in the company’s copyright fight over generative AI.

A recent Wall Street commentary, published via Yahoo Finance on June 5, framed The Walt Disney Company as one of the “top cheap stocks” carrying Strong Buy ratings. The post did not provide analyst-by-analyst rating counts or valuation multiples, but it tied the discussion to two prominent developments involving Disney’s IP, including a healthcare technology collaboration announced May 28 and a U.S. court decision reported May 26.

On May 28, Royal Philips and Disney said they are integrating Disney characters and stories directly into Philips Ambient Experience for MRI, a patient-experience system designed to make magnetic resonance imaging scans less stressful. Philips said the themed content is incorporated into the Ambient Experience environment for medical facilities in 87 countries, specifically to support children undergoing imaging procedures by diverting attention from the clinical setting and making scans more engaging.

Disney and Philips also described the operational challenge they are targeting. They said pediatric patients can experience anxiety when entering a large, unfamiliar scanner, and that MRI exams can require children to remain still for up to 40 minutes. According to the announcement, 66% of pediatric patients report feeling anxious during MRI scans, anxiety that can contribute to longer procedures, re-scans, or in some cases sedation, which can in turn limit how many patients care teams can see each day.

The companies cited supporting data from a multi-center study conducted across six European hospitals. For children ages 6 to 10, the announcement said post-scan pediatric patient stress levels were reduced by 43% compared with pre-exam conditions, and that pauses during scans dropped by 63% compared with procedures without the intervention. Philips said Ambient Experience uses calming lighting, sound, and visual elements, with Disney-themed content added to reduce anxiety and stress during exams.

Disney said it is providing the art and imagery “at no cost” as part of an ongoing charitable commitment. The announcement said children and families can choose among characters including Mickey and Minnie Mouse, Marvel superheroes, favorites from Star Wars, and Disney Princesses, among others. It also said Philips Ambient Experience for MRI is the exclusive MRI platform using these Disney themes, with early adopters including Rady Children’s Health in Orange County and Calderdale Royal Hospital.

Separate from the healthcare push, a Reuters report carried by Yahoo-related coverage on May 26 described a U.S. judge rejecting an effort by China’s MiniMax to dismiss Disney’s AI copyright lawsuit. The case centers on MiniMax’s Hailuo generative AI system, which the studios allege was built using copyrighted material and marketed with Disney and other Hollywood characters. Reuters reported that U.S. District Judge Stanley Blumenfeld rejected MiniMax arguments that the studios had not made a valid claim and that the U.S. court lacked jurisdiction, saying there was evidence the Hailuo app was offered in the United States.

Still, several details that investors typically want were not fully disclosed in the market-news note that sparked the “cheap stock” framing. The post did not specify which analysts issued Strong Buy ratings, how many covered the stock, what price targets were used, or what valuation basis supported the “cheap” characterization. Likewise, the Disney-Philips announcement did not disclose contract economics, such as pricing, duration, or expected financial impact. That leaves investors to watch for follow-on disclosures about adoption, outcomes, and whether the partnership expands beyond early hospitals. The next steps to monitor are new rollout updates across the 87-country footprint and any further rulings in the MiniMax AI copyright case, both of which could influence how investors view Disney’s brand licensing strategy and IP enforcement risk.

Why It Matters

  • The Disney-Philips deal is an example of Disney IP being applied beyond entertainment into healthcare settings, which could shape how investors think about brand monetization opportunities.
  • Pediatric MRI comfort features may improve scan completion and workflow efficiency, though the announcement did not quantify financial benefits to Disney.
  • The MiniMax ruling keeps Disney’s AI copyright case moving, reflecting ongoing legal uncertainty around the use of copyrighted characters in generative AI systems.
  • The “cheap stock” framing depends on analyst views and valuation assumptions that were not specified in the market-news post, so sentiment could shift as more details emerge.

Sources

Key Facts

  • A Yahoo Finance market-news post published June 5 described Disney (DIS) as one of the “top cheap stocks” with Strong Buy ratings, without listing specific analyst counts or valuation metrics.
  • On May 28, Disney and Royal Philips said Disney stories and characters will be incorporated into Philips Ambient Experience for MRI in medical facilities in 87 countries.
  • Philips Ambient Experience for MRI is intended to make MRI scans more comfortable for pediatric patients using calming visuals and audio, with Disney-themed content added to divert attention.
  • Disney and Philips said the cited intervention targeted pediatric scan anxiety, where they reported 66% of pediatric patients feel anxious during MRI scans.
  • The May 28 announcement cited study results for ages 6 to 10 showing a 43% reduction in post-scan stress levels and a 63% reduction in scan pauses versus procedures without the intervention.
  • Disney said it is providing the art and imagery for the MRI experience at no cost, and named early adopters including Rady Children’s Health and Calderdale Royal Hospital.
  • A Reuters report on May 26 said a U.S. judge rejected MiniMax’s bid to dismiss Disney-related AI copyright claims over its Hailuo image-and-video generator.

Media & Telecom Related

Disney brands, MRI technology, and AI copyright battles are in focus as Wall Street branding calls DIS a “cheap” buy | The Apex Times